Citadel Advisors
EVLO

Citadel Advisors’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Citadel Advisors’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-498
Closed -$16K – 16035
2022
Q4 		$16K Buy
+498
New +$19.7K ﹤0.01% 13295
2022
Q3 		– Sell
-5,371
Closed -$246K – 14289
2022
Q2 		$226K Buy
5,371
+2,219
+70% +$103K ﹤0.01% 10451
2022
Q1 		$214K Buy
3,152
+263
+9% +$21.9K ﹤0.01% 11366
2021
Q4 		$351K Buy
+2,889
New +$488K ﹤0.01% 10564
2021
Q3 		– Sell
-974
Closed -$193K – 15186
2021
Q2 		$268K Sell
974
-811
-45% -$205K ﹤0.01% 11540
2021
Q1 		$382K Buy
1,785
+652
+58% +$180K ﹤0.01% 10298
2020
Q4 		$274K Buy
+1,133
New +$140K ﹤0.01% 9226
2020
Q2 		– Sell
-511
Closed -$38K – 10820
2020
Q1 		$38K Buy
+511
New +$48.7K ﹤0.01% 9131

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return